Prevention of Adverse Reactions to Allergen Immunotherapy With Omalizumab: A Retrospective Study
Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1465-1468
DOI: 10.1111/cea.70405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 05.08.2026. Verfasst von Keru Shang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Die Arbeit nennt 8 Literaturangaben. Gefördert von: Shanghai Municipal Science and Technology Commission Foundation, Shanghai Jiao Tong University Inner Mongolia Research Institute.
Abstract (Originalsprache)
OMA reduces AIT‐related adverse reactions in paediatric allergic disorders. OMA adjunctive AIT optimises therapy for high‐risk paediatric asthma patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Ordos Maternal and Child Healthcare Hospital, Ordos, China.
ORCID-Profile: Keru Shang, Jiaying Shi, Jinhong Wu
Förderung
- Shanghai Municipal Science and Technology Commission Foundation
- Shanghai Jiao Tong University Inner Mongolia Research Institute
Zitieren
APA
Shang, K., Wu, Z., Shi, J., Yu, H., Cheng, L., Zhang, H., & Wu, J. (2026). Prevention of Adverse Reactions to Allergen Immunotherapy With Omalizumab: A Retrospective Study. Clinical & Experimental Allergy, 56(11), 1465-1468. https://doi.org/10.1111/cea.70405
Vancouver
Shang K, Wu Z, Shi J, Yu H, Cheng L, Zhang H, et al. Prevention of Adverse Reactions to Allergen Immunotherapy With Omalizumab: A Retrospective Study. Clinical & Experimental Allergy. 2026;56(11):1465-1468. doi:10.1111/cea.70405
BibTeX
@article{Shang2026,
author = {Shang, Keru and Wu, Ziqin and Shi, Jiaying and Yu, Haoyue and Cheng, Le and Zhang, Hengai and Wu, Jinhong},
title = {Prevention of Adverse Reactions to Allergen Immunotherapy With Omalizumab: A Retrospective Study},
journal = {Clinical & Experimental Allergy},
year = {2026},
volume = {56},
number = {11},
pages = {1465--1468},
doi = {10.1111/cea.70405}
}
EUVIMED